CAPLIPOINT - Caplin Point Laboratories

Caplin Point Laboratories

CAPLIPOINT · Pharma > Pharmaceuticals & Drugs · Chairman: C C Paarthipan · MD: Sridhar Ganesan · Listing date: June 23, 2014 · Employees: 1675 · Chennai · http://www.caplinpoint.net

Stock Price vs Company Growth

3.1%

4.7%

6.2%

4.1%

13.7%

9.5%

31.3%

10y

23.9%

all

39.6%

🤔 How to analyze this graph?

Last Traded Price

₹ 1,739 3.1%

1,502

1,952

Company Overview

Sales

2,089 Cr

Growth: 11.3%

Profit after Tax

614 Cr

Growth: 4.2%

Mid Cap

13,215 Cr

P/E: 21.6x

Industry P/E: 28.0x

Fundamentals

Sales (Cr)	₹ 2,089
Growth	11.3%
EBITDA	34.7%
P/S	6.3x
Dividend	0.3%
P/E	21.6x
Book Value	₹ 437
PEG Ratio	1.9x
ROE	19.9%
P/B	3.9x

Shareholding Pattern

Institutions

Promoters

P Vijayalakhsmi

23.64 %

Paarthipan C C

18.73 %

Ashok Gorkey Partheeban

11.96 %

Partheeban Vivek Siddarth

11.9 %

May India Property Private Limited

2.8 %

Others

Iepf

2.46 %

Visalatchi

2.22 %

Suresh Kumar Agarwal

1.32 %

Ashish Kacholia

1.16 %

Llp

0.7 %

Increase Decrease No change

Company Profile Detailed

Caplin Point Laboratories is engaged in manufacture of pharmaceuticals formulations. It is a fast-growing Indian pharmaceutical company with global reach, having a 100% export-oriented business. The company supplies a complete range of finished dosage forms. The company operates on a unique business model which predominantly caters to emerging markets of Latin America and Africa and a growing presence in regulated markets like the USA, Canada, Australia etc.

Belongs to (21 Indices) view more

Investors (50)

liabilit...

vikramjo...

partheeb...

Followers (28)

rohit66

damerla

bhaskar2